Список литературы к главе 6

27. Jauniaux E., Hempstock J., Greenwold N., Burton G.J. Trophoblastic oxidative stress in relation to temporal and regional differences in maternal placental blood flow in normal and abnormal early pregnancies // Am. J. Pathol. 2003. Vol. 162. P. 115–125. DOI: 10.1016/S0002-9440(10)63803-5.

28. Rasouli N., Kern P.A. Adipocytokines and the metabolic complications of obesity // J. Clin. Endocrinol. Metab. 2008. Vol. 93, N 11. Suppl. 1. P. S64–S73. DOI: 10.1210/jc.2008-1613.

29. Galic S., Oakhill J.S., Steinberg G.R. Adipose tissue as an endocrine organ // Mol. Cell Endocrinol. 2010 Vol. 316. P. 129–139. DOI: 10.1016/j.mce.2009.08.018.

30. Henry B.A., Clarke I.J. Adipose tissue hormones and the regulation of food intake // J. Neuroendocrinol. 2008. Vol. 20, N 6. P. 842–849. DOI: 10.1111/j.1365-2826.2008.1730.x.

31. Kapustin R.V., Drobintseva A.O., Alekseenkova E.N., Onopriychuk A.R., Arzhanova O.N., Polyakova V.O., Kvetnoy I.M. Placental protein expression of kisspeptin-1 (KISS1) and the kisspeptin-1 receptor (KISS1R) in pregnancy complicated by diabetes mellitus or preeclampsia // Arch. Gynecol. Obstet. 2020. Vol. 301, N 2. P. 437–445. DOI: 10.1007/s00404-019-05408-1.

32. Kitzmiller J.L., Block J.M., Brown F.M., Catalano P.M., Conway D.L., Coustan D.R. et al. Managing preexisting diabetes for pregnancy: summary of evidence and consensus recommendations for care // Diabetes Care. 2008. Vol. 31, N 5. P. 1060–1079. DOI: 10.2337/dc08-9020.

33. Eriksson U.J., Wentzel P. The status of diabetic embryopathy // Ups. J. Med. Sci. 2016. Vol. 121, N 2. P. 96–112. DOI: 10.3109/03009734.2016.1165317.

34. De Franco S., Chiocchetti A., Ferretti M., Castelli L., Cadario F., Cerutti F. et al. Defective function of the Fas apoptotic pathway in type 1 diabetes mellitus correlates with age at onset // Int. J. Immunopathol. Pharmacol. 2007. Vol. 20, N 3. P. 567–576. DOI: 10.1177/039463200702000314.

35. Ding Z., Zhou H., McCauley N., Ko G., Zhang K.K., Xie L. In ovo hyperglycemia causes congenital limb defects in chicken embryos via disruption of cell proliferation and apoptosis // Biochim. Biophys. Acta. Mol. Basis. Dis. 2020. Vol. 1866, N 12. P. 165955. DOI: 10.1016/j.bbadis.2020.165955.

36. Freinkel N., Cockroft D.L., Lewis N.J., Gorman L., Akazawa S., Phillips L.S., Shambaugh G.E. 3rd. The 1986 McCollum award lecture. Fuel-mediated teratogenesis during early organogenesis: the effects of increased concentrations of glucose, ketones, or somatomedin inhibitor during rat embryo culture // Am. J. Clin. Nutr. 1986. Vol. 44, N 6. P. 986–995. DOI: 10.1093/ajcn/44.6.986.

37. Mills J.L., Knopp R.H., Simpson J.L., Jovanovic-Peterson L., Metzger B.E., Holmes L.B. et al. Lack of relation of increased malformation rates in infants of diabetic mothers to glycemic control during organogenesis // N. Engl. J. Med. 1988. Vol. 318. P. 671–676. DOI: 10.1056/NEJM198803173181104.

38. Greene M.F. Spontaneous abortions and major malformations in women with diabetes mellitus // Semin. Reprod. Endocrinol. 1999. Vol. 17, N 2. P. 127–136. DOI: 10.1055/s-2007-1016220.

39. Cundy T., Gamble G., Neale L., Elder R., McPherson P. et al. Differing causes of pregnancy loss in type 1 and type 2 diabetes // Diabetes Care. 2007. Vol. 30, N 10. P. 2603–2607. DOI: 10.2337/dc07-0555.

40. Gutaj P., Zawiejska A., Wender-Ożegowska E., Brązert J. Maternal factors predictive of first-trimester pregnancy loss in women with pregestational diabetes // Pol. Arch. Med. Wewn. 2013. Vol. 123, N 1–2. P. 21–28. DOI: 10.20452/pamw.1585.

41. Rosenn B.M., Miodovnik M., Holcberg G., Khoury J.C., Siddiqi T.A. Hypoglycemia: the price of intensive insulin therapy for pregnant women with insulin-dependent diabetes mellitus // Obstet. Gynecol. 1995. Vol. 85, N 3. P. 417–422. DOI: 10.1016/0029-7844(94)00415-A.

42. Zisser H.C., Biersmith M.A., Jovanovič L.B., Yogev Y., Hod M., Kovatchev B.P. Fetal risk assessment in pregnancies complicated by diabetes mellitus // J. Diabetes Sci. Technol. 2010. Vol. 4. P. 1368–1373. DOI: 10.1177/193229681000400610.

43. Jovanovic L., Knopp R.H., Kim H., Cefalu W.T., Zhu X.D., Lee Y.J. et al. Elevated pregnancy losses at high and low extremes of maternal glucose in early normal and diabetic pregnancy: evidence for a protective adaptation in diabetes // Diabetes Care. 2005. Vol. 28, N 5. P. 1113–1117. DOI: 10.2337/diacare.28.5.1113.

44. Casson I.F., Clarke C.A., Howard C.V., McKendrick O., Pennycook S., Pharoah P.O. et al. Outcomes of pregnancy in insulin dependent diabetic women: results of a five year population cohort study // BMJ. 1997. Vol. 315, N 7103. P. 275–278. DOI: 10.1136/bmj.315.7103.275.

45. Sacks D.A., Feig D.S. Caring for pregnant women whose diabetes antedates pregnancy: is there room for improvement? // Diabetologia. 2018. Vol. 61, N 5. P. 1022–1026. DOI: 10.1007/s00125-018-4565-7.

46. Murphy H.R., Bell R., Cartwright C., Curnow P., Maresh M., Morgan M. et al. Improved pregnancy outcomes in women with type 1 and type 2 diabetes but substantial clinic-to-clinic variations: a prospective nationwide study // Diabetologia. 2017. Vol. 60, N 9. P. 1668–1677. DOI: 10.1007/s00125-017-4314-3.

47. Айламазян Э.К., Боровик Н.В., Потин В.В., Тиселько А.В. Подготовка женщин с сахарным диабетом к беременности // Доктор Ру. 2014. Т. 12. С. 34–38.

48. Гафарова Е.А., Замалеева Р.С., Коган Я.Э. Особенности прегравидарной подготовки женщин с нарушениями углеводного обмена и риском развития гестационного диабета // Практическая медицина. 2017. № 7 (108). С. 41–46.

49. Ших Е.В., Махова А.А. Преимущества проведения коррекции фолатного статуса с использованием витаминно-минерального комплекса, содержащего Метафолин // Трудный пациент. 2013. № 11. С. 26–31.

50. Araújo J.R., Correia-Branco A., Moreira L., Ramalho C., Martel F., Keating E. Folic acid uptake by the human syncytiotrophoblast is affected by gestational diabetes, hyperleptinemia, and TNF-α // Pediatr. Res. 2013. Vol. 73, N 4. Pt. 1. P. 388–394. DOI: 10.1038/pr.2013.14.

51. Essential nutrition actions: mainstreaming nutrition through the life-course. Geneva: World Health Organization, 2019. Licence: CC BY-NC-SA 3.0 IGO.

52. Diabetes in pregnancy: management from preconception to the postnatal period. London: National Institute for Health and Care Excellence (NICE). 2020. Dec 16. PMID: 32212588.

53. Wiens D., DeSoto M.C. Is High Folic Acid Intake a Risk Factor for Autism? // A Review Brain Sci. 2017. Vol. 7, N 11. P. 149. DOI: 10.3390/brainsci7110149.

54. Metwally M., Ong K.J., Ledger W.L., Li T.C. Does high body mass index increase the risk of miscarriage after spontaneous and assisted conception? A meta-analysis of the evidence // Fertil. Steril. 2008. Vol. 90, N 3. P. 714–726. DOI: 10.1016/j.fertnstert.2007.07.1290.

55. Cavalcante M.B., Sarno M., Peixoto A.B., Araujo Júnior E., Barini R. Obesity and recurrent miscarriage: a systematic review and meta-analysis // J. Obstet. Gynaecol. Res. 2019. Vol. 45, N 1. P. 30–38. DOI: 10.1111/jog.13799.

56. Zhou H., Liu Y., Liu L., Zhang M., Chen X., Qi Y. Maternal pre-pregnancy risk factors for miscarriage from a prevention perspective: a cohort study in China // Eur. J. Obstet. Gynecol. Reprod. Biol. 2016. Vol. 206. P. 57–63. DOI: 10.1016/j.ejogrb.2016.07.514.

57. Sun Y.F., Zhang J., Xu Y.M., Cao Z.Y., Wang Y.Z., Hao G.M., Gao B.L. High BMI and insulin resistance are risk factors for spontaneous abortion in patients with polycystic ovary syndrome undergoing assisted reproductive treatment: a systematic review and meta-analysis // Front. Endocrinol (Lausanne). 2020. Vol. 11. P. 592495. DOI: 10.3389/fendo.2020.592495.

58. Nobles C.J., Mendola P., Mumford S.L., Naimi A.I., Yeung E.H., Kim K. et al. Preconception blood pressure levels and reproductive outcomes in a prospective cohort of women attempting pregnancy // Hypertension. 2018. Vol. 71, N 5. P. 904–910. DOI: 10.1161/HYPERTENSIONAHA.117.10705.

59. Wong S.F., Chan F.Y., Cincotta R.B., Oats J.J., McIntyre H.D. Routine ultrasound screening in diabetic pregnancies // Ultrasound Obstet. Gynecol. 2002. Vol. 19, N 2. P. 171–176. DOI: 10.1046/j.0960-7692.2001.00560.x.